Lunai Bioworks LNAI
NASDAQ LNAI
$1.38 -0.09 (-6.10%)
At close: Oct 1, 2026 · 4:00 PM EDT

Lunai Bioworks (LNAI) Non Operating Interest Expenses (2012 - 2026)

Updated

Lunai Bioworks' Non Operating Interest Expenses came in at $108,052 for fiscal Q3 2026 (quarter ended Mar 31, 2026), down 42.7% from $188,685 a year earlier and down 11.1% from the prior quarter.

Analysis

Lunai Bioworks (LNAI) Non Operating Interest Expenses (2012 - 2026) Analysis & Trends

Over the trailing twelve months to Mar 31, 2026, Lunai Bioworks reported Non Operating Interest Expenses of $539,988, down 31.7% year-over-year; for FY2025 (ended Jun 30, 2025), it came in at $725,684, down 28.2% from FY2024.

  • Non Operating Interest Expenses carries a five-year compound annual growth rate of 47.4% (FY2020 to FY2025).
  • Going back by fiscal year, Non Operating Interest Expenses was $1.01 million in FY2024 (+74.3%), $580,344 in FY2023 (+55.7%), $372,844 in FY2022 (-1.8%) and $379,608 in FY2021 (+264.0%).
  • The fiscal Q3 2026 figure represents the lowest quarterly Non Operating Interest Expenses since fiscal Q2 2025.
  • Year-over-year, Non Operating Interest Expenses increased in two of the last eight quarters, with an average decline of 20.6%.
  • The fastest year-over-year change in Non Operating Interest Expenses over five years came in fiscal Q2 2024 (growth of 196.0%), and the weakest in fiscal Q3 2022 (a decline of 65.8%).
  • Business Quant data shows LNAI's Non Operating Interest Expenses at $121,508 (Q2 2026), $122,400 (Q1 2026) and $188,028 (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Lunai Bioworks 4.59 Mn -159,591.66 20,942.00 108,052.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 108,052.00
Dec 31, 2025 121,508.00
Sep 30, 2025 122,400.00
Jun 30, 2025 188,028.00
Mar 31, 2025 188,685.00
Dec 31, 2024 98,891.00
Sep 30, 2024 250,080.00
Jun 30, 2024 253,265.00
Mar 31, 2024 303,802.00
Dec 31, 2023 274,984.00
Sep 30, 2023 179,271.00
Jun 30, 2023 269,578.00
Mar 31, 2023 122,289.00
Dec 31, 2022 92,892.00
Sep 30, 2022 95,585.00
Jun 30, 2022 94,517.00
Mar 31, 2022 95,206.00
Dec 31, 2021 93,382.00
Sep 30, 2021 89,739.00
Jun 30, 2021 97,522.00
API Access

Lunai Bioworks Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=LNAI&period=max&api_key=YOUR_API_KEY